Repurposing therapeutic drugs for COVID-19 : research challenges and opportunities : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, second session, June 19, 2020
Electronic resources
Record details
-
Physical Description:
1 online resource (iii, 75 pages) : illustration
remote - Publisher: Washington : U.S. Government Publishing Office, 2021.
Content descriptions
| General Note: | "Serial no. 116-74." Access ID (govinfo): CHRG-116hhrg40634. GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography, etc. Note: | Includes bibliographical references. |
| Participant or Performer Note: | Hearing witnesses: Dr. Peter Lurie, President, Center for Science in the Public Interest; Dr. James Finigan, Director of the Respiratory Centers of Excellence, National Jewish Health; Dr. Rick L. Stevens, Associate Laboratory Director for Computing, Environment and Life Sciences, Argonne National Laboratory; Dr. Benjamin Rome, Associate Physician, Brigham and Women's Hospital; Postdoctoral Research Fellow, Harvard Medical School. |
| Date/Time and Place of an Event Note: | Date of hearing: 2020-06-19. |
| Source of Description Note: | Description based on online resource; title from PDF title page (govinfo, viewed Feb. 3, 2021). |
Search for related items by subject
| Subject: | COVID-19 (Disease) Treatment United States COVID-19 (Disease) United States Drugs Research United States |
| Genre: | Legislative hearings. |
